Rahul S Patel, MD

Clinical Focus

• Angiography
• Arteriovenous Malformations
• Atherosclerosis
• Chronic Venous Insufficiency
• Deep Vein Thrombosis
• Interventional Oncology
• Interventional Radiology Treatment
• Liver Cancer
• Peripheral Vascular Disease

Show More

• Angiography
• Arteriovenous Malformations
• Atherosclerosis
• Chronic Venous Insufficiency
• Deep Vein Thrombosis
• Interventional Oncology
• Interventional Radiology Treatment
• Liver Cancer
• Peripheral Vascular Disease
• Radiofrequency Ablation
• Renal Artery Stenosis
• Varicose Veins

Locations

Physician Office

5 E 98th Street, 12th Floor, New York, NY, 10029

212-241-4046

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:18

Article:56

Review Article:4

Comment/Debate:1

Recent Artifacts

• Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma
• Splanchnic vein thrombosis associated with myeloproliferative neoplasms
• The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors
• Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study
• Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
• Intrahepatic flow diversion prior to segmental Yttrium-90 radioembolization for challenging tumor vasculature
• Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma
• Contemporary Management of Acute Pulmonary Embolism: Evolution of Catheter-based Therapy
• Double-barrel iliocaval reconstruction using closed-cell dedicated venous stents
• Nausea and Vomiting 8 Months After Liver Transplantation

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Patel during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.